Get started
Live feed
·
PRReleasevia Quantisnow
enGene Therapeutics Inc. logo

enGene Reports Second Quarter 2025 Financial Results and Provides Business Update

ByQuantisnow·Wall Street's wire, on your screen.
ENGNenGene Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENGN (enGene Therapeutics Inc.) and more on Quantisnow.